CHO Cell Vector Set for Multispecific Antibody Purity Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for producing multispecific antibodies face challenges in achieving high expression levels and purity due to variations in transcription and translation rates, polypeptide decomposition, mispairing of H and L chains, and difficulties in determining optimal expression ratios, leading to inefficient production of multispecific antibodies.

Innovation Solution

A method involving the introduction of a first and second expression vector into a host cell, where the first vector contains all four types of polypeptide cassettes and the second vector enhances the expression of a specific polypeptide, allowing for selection of cells with optimal expression levels and purity through criteria such as expression level and purity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Device complexity

If all four types of expression cassettes are inserted into one expression vector, then the device complexity is reduced, but the manufacturing precision of the multispecific antibody decreases due to variations in transcription and translation rates

Engineering Contradiction:
Improvenumber of expression vectorsVSAvoidpurity of multisspecific antibody
Core Design Contradiction:
Device complexityVSManufacturing precision

Solution Approach 1:

The expression cassettes are divided into two groups and inserted into two separate expression vectors. The first expression vector contains expression cassettes for polypeptides that require higher expression levels, while the second expression vector contains expression cassettes for polypeptides that require lower expression levels. This segmentation allows independent control of expression levels for each polypeptide, improving the purity of the multispecific antibody by preventing mispairing and aggregation.

Inventive Principle:
Principle #1Segmentation

2Manufacturing precision

If expression cassettes are inserted into separate expression vectors, then the manufacturing precision of the multisspecific antibody is improved, but the device complexity increases due to the need for multiple vectors and selection markers

Engineering Contradiction:
Improvepurity of multisspecific antibodyVSAvoidnumber of expression vectors
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

Both expression vectors utilize the same selection marker (e.g., antibiotic resistance gene), allowing for unified selection of host cells that have successfully taken up either vector. This multi-functionality approach reduces the need for multiple different selection markers, thereby limiting the increase in device complexity while still maintaining the benefit of separate expression control for improved antibody purity.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Productivity

If the optimal ratio of expression levels is determined in advance, then the productivity is improved, but the manufacturing precision decreases due to difficulty in determining the optimal ratio for four types of polypeptides

Engineering Contradiction:
Improveexpression level of multisspecific antibodyVSAvoidpurity of multisspecific antibody
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

Instead of applying a uniform expression level ratio to all four polypeptides, the invention applies different expression levels to different polypeptides based on their specific requirements. By controlling the number of expression cassettes in each vector, the invention achieves local optimization of expression levels, ensuring that each polypeptide is produced at the appropriate concentration to maintain high purity while maximizing overall productivity.

Inventive Principle:
Principle #3Local quality

4Productivity

If a specific polypeptide is overexpressed to compensate for decomposition, then the productivity is improved, but the manufacturing precision worsens due to aggregation of excess polypeptides

Engineering Contradiction:
Improveexpression level of multisspecific antibodyVSAvoidpurity of multisspecific antibody
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The invention provides a dynamic approach to controlling polypeptide expression by allowing flexible adjustment of the number of expression cassettes for each polypeptide. This dynamic control enables optimization of expression levels to compensate for decomposition of unstable polypeptides while preventing overexpression that would lead to aggregation. The balanced expression levels are maintained by adjusting cassette numbers rather than using fixed overexpression strategies.

Inventive Principle:
Principle #15Dynamics

Data Source

PatentEP4650440A1Method for producing cell, method for producing multispecific antibody, vector set, mammalian cell, CHO cell, and method for producing cell pool
Publication Date: 2025.11.19 FUJIFILM CORP
  • EP4650440A1 patent drawingFigure 1~2
  • EP4650440A1 patent drawingFigure 3
  • EP4650440A1 patent drawingFigure 4

AI summary

A vector set is introduced into a host cell, and a cell that produces a multispecific antibody is selected from the host cell into which the vector set has been introduced. The vector set is a set of a first expression vector and a second expression vector, in which the first expression vector contains an expression cassette of a first H chain, an expression cassette of a second H chain, an expression cassette of a first L chain, and an expression cassette of a second L chain, and the second expression vector contains one type, two types, or three types of expression cassettes selected from the group consisting of the expression cassette of the first H chain, the expression cassette of the second H chain, the expression cassette of the first L chain, and the expression cassette of the second L chain.